Joseph Casadonte
Neurology with Special Qualifications in Child Neurology · St Petersburg, FLNPI 1982632162
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 182 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 23.0% — the pattern of someone who eats at a lot of different presentations.
Across 182 payments — averaging $21.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$894
- SK Life Science, Inc.$423
- Jazz Pharmaceuticals Inc.$422
- Aquestive Therapeutics, Inc.$238
- Neurelis, Inc.$228
- Supernus Pharmaceuticals, Inc.$207
- plus $1K from 26 others
What the payments were for
- Food & beverage$3,884100%
- Education$30%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 41 | $894 |
| SK Life Science, Inc. | 13 | $423 |
| Jazz Pharmaceuticals Inc. | 17 | $422 |
| Aquestive Therapeutics, Inc. | 11 | $238 |
| Neurelis, Inc. | 11 | $228 |
| Supernus Pharmaceuticals, Inc. | 13 | $207 |
| Eisai Inc. | 8 | $161 |
| Corium, LLC | 9 | $152 |
| Azurity Pharmaceuticals, Inc. | 5 | $128 |
| Acadia Pharmaceuticals Inc | 5 | $121 |
| Ironshore Pharmaceuticals Inc. | 5 | $90 |
| Tris Pharma Inc | 5 | $87 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $86 |
| Collegium Pharmaceutical, Inc. | 3 | $62 |
| Harmony Biosciences LLC | 2 | $61 |
| Catalyst Pharmaceuticals, Inc. | 2 | $50 |
| Novartis | 3 | $48 |
| Noven Therapeutics, LLC | 2 | $44 |
| Cranial Technologies, Inc | 2 | $40 |
| Zogenix Inc. | 2 | $37 |
| Greenwich Biosciences, Inc. | 2 | $37 |
| Upsher-smith Laboratories LLC | 2 | $35 |
| Aucta Pharmaceuticals, Inc. | 3 | $33 |
| Sumitomo Pharma America, Inc. | 2 | $33 |
| Intrabio Inc | 1 | $28 |
| Livanova USA, Inc. | 1 | $25 |
| Biohaven Pharmaceuticals, Inc. | 1 | $23 |
| Travere Therapeutics, Inc. | 3 | $21 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $20 |
| Immedica Pharma US, Inc. | 1 | $19 |
| Amneal Pharmaceuticals LLC | 1 | $19 |
| Biomarin Pharmaceutical Inc. | 1 | $14 |
How this compares
$3,887 in reported general payments places this provider in the 55th percentile of 137 neurology with special qualifications in child neurology providers in Florida.
See all neurology with special qualifications in child neurology providers in Florida →
Other neurology with special qualifications in child neurology in St Petersburg
- Thomas GellerSt Petersburg$6K
- Neel ParikhSt Petersburg$6K
- Ena AndrewsSt Petersburg$5K
- Vinod ValentineSt Petersburg$5K
- Paul WinnerWest Palm Beach$624K
- Omer Abdul HamidOrlando$283K
- Natalie GillsonFort Myers$250K
- Trevor ResnickMiami$230K
- Migvis MonduyMiami$188K
- Elza VasconcellosMiami$170K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.